Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Aug 1;42(6):852-886.
doi: 10.1177/0011000014542601. Epub 2014 Jul 17.

Culturally-Tailored Smoking Cessation for Adult American Indian Smokers: A Clinical Trial

Stevens S Smith  1 , Leah M Rouse  2 , Mark Caskey  3 , Jodi Fossum  3 , Rick Strickland  4 , J Kevin Culhane  3 , Jerry Waukau  3
Affiliations

Culturally-Tailored Smoking Cessation for Adult American Indian Smokers: A Clinical Trial

Stevens S Smith et al. Couns Psychol. .

Abstract

This collaborative, community-engaged project developed and tested a Culturally-Tailored Treatment (CTT) for American Indian/Alaska Native (AI/AN) smokers in the Menominee tribal community. One hundred three adult AI/AN smokers were randomized to receive either Standard Treatment (n= 53) or CTT (n = 50) for smoking cessation. Both treatment conditions included 12 weeks of varenicline and four individual counseling sessions but differed in terms of cultural tailoring of the counseling. The primary outcome was 7-day biochemically-confirmed point-prevalence abstinence (PPA) at the 6-month end-of-study visit. Both intention-to-treat (ITT) and responder-only analyses were conducted. There were no statistically significant group differences in 7-day PPA. The overall ITT abstinence rate at 6 months was 20%; the responder-only rate was 42%. The current study represents the first randomized smoking cessation clinical trial testing a culturally-tailored smoking cessation intervention designed for a specific AI/AN tribal community that combined FDA-approved cessation medication (varenicline) and innovative cultural intervention components.

PubMed Disclaimer

Figures

Figure 1
Figure 1
CONSORT diagram and study visit schedule.
See this image and copyright information in PMC

References

    1. Ahrens D, Bandi P, Ullsvik J, Moberg DP. Who smokes? A demographic analysis of Wisconsin smokers. Wisconsin Medical Journal. 2005;104:18–22. - PubMed
    1. Arndt L, Caskey M, Fossum J, Schmidt N, Davis A, Smith SS, Waukau J. Menominee perspectives on commercial and sacred tobacco use. American Indian and Alaska Native Mental Health Research. 2013;20:1–22. doi: 10.5820/aian.2003.2013.1. - DOI - PMC - PubMed
    1. Baker TB, Piper ME, McCarthy DE, Bolt DM, Smith SS, Kim SY, Toll BA. Time to first cigarette in the morning as an index of ability to quit smoking: Implications for nicotine dependence. Nicotine & Tobacco Research. 2007;9:S555–S570. doi: 10.1080/14622200701673480. - DOI - PMC - PubMed
    1. Bolt DM, Piper ME, McCarthy DE, Japuntich SJ, Fiore MC, Smith SS, Baker TB. The Wisconsin Predicting Patients’ Relapse Questionnaire. Nicotine & Tobacco Research. 2009;11:481–492. doi: 10.1093/ntr/ntp030. - DOI - PMC - PubMed
    1. Brave Heart M, Chase J, Elkins J, Altschul DB. Historical trauma among indigenous peoples of the Americas: Concepts, research, and clinical considerations. Journal of Psychoactive Drugs. 2011;43(4):282–290. doi: 10.1080/02791072.2011.628913. - DOI - PubMed

LinkOut - more resources